ストックスクリーナーアプリを入手
37.31
6.52%
-2.6024
プレマーケット:
37.50
0.19
+0.51%
前日終値:
$39.91
開ける：
$40.55
24時間の取引高:
74,366
Relative Volume:
1.38
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+6.17%
1か月 パフォーマンス:
-32.63%
6か月 パフォーマンス:
-43.36%
1年 パフォーマンス:
-28.29%
1日の値動き範囲:
$36.24
$40.55
1週間の範囲:
$36.24
$42.66
52週間の値動き範囲:
$18.25
$94.00
Tradr 2 X Long Innovation Etf Stock (TARK) Company Profile
Compare TARK vs VTI, SPY, IVV, VB, QQQ
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TARK
Tradr 2 X Long Innovation Etf
|
37.31 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
336.01 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
681.27 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
684.33 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
272.94 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
600.64 | 124.43B | 0 | 0 | 0 | 0.00 |
Tradr 2 X Long Innovation Etf (TARK) 最新ニュース
Bloom Energy, NuScale Power Buzz Drives ETF Action — Tradr Bets Double-Down Bear Plays - Benzinga
Alopecia Areata Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Pfizer, Legacy Healthcare, AnaptysBio, Eli Lilly and Company, Incyte, Novartis - Barchart.com
Breast Cancer Clinical Trial Pipeline Expands as 250+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
As Crypto Prices Plunge, Cathie Wood Is Selling This 1 Bitcoin Stock - Barchart.com
Ichthyosis Market: Rapid Increment Driven by Innovation – DelveInsight | Timber Pharma, Krystal Biotech, GSK, Timber Pharma, Janssen Scientific - Barchart.com
Diabetes Clinical Trial Pipeline Expands as 200+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
Resideo Wins Two 2026 IoT Breakthrough Awards for Smart Home Innovation - Barchart.com
Bladder Cancer Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Bristol-Myers Squibb Company, GlaxoSmithKline PLC., Johnson & Johnson, Janssen Pharma, F. Hoffmann-La Roche., Merck - Barchart.com
Vonage Wins Two Juniper Research Awards for Innovation in Network and Mobile Identity Solutions - Barchart.com
Tradull’s Innovative Model: Enabling Individual Participation in Global Commodities Trade - Barchart.com
VenHub Wins RTIH Award for Most Innovative Retailer - Barchart.com
CMG Q4 Deep Dive: Value Push, Menu Innovation, and Margins Under Pressure - Barchart.com
Cathie Wood Keeps Buying Joby Aviation Stock. Should You? - Barchart.com
Lindemann & Partner Launches Innovative Platform for Certified Contract Terminations in Germany - Barchart.com
Clarivate Webinar "Intelligence Amplified in the Age of AI" Highlights How Trusted, Proprietary Data Powers Next‑Generation Innovation - Barchart.com
PayPal Appoints Enrique Lores as Chief Executive Officer and David W. Dorman as Independent Board Chair - Barchart.com
Orbit Capital Announces Founder First Ecosystem Supporting 45 Companies - Barchart.com
Dr. Nitun Ahir Establishes New Academic Scholarship to Foster Innovation and Strategic Leadership in Modern Medicine - Barchart.com
Dr. Robert Corkern Award for Entrepreneurs Announces 2026 Application Cycle for Undergraduate Innovators - Barchart.com
Global RSV Vaccines Market Set to Reach US$1.24 Billion by 2030 - Barchart.com
Cognizant and Ace Hardware Celebrate 25 Years of Partnership to Advance Next-Generation E-Commerce and Supply Chain Innovation - Barchart.com
Cathie Wood Just Bet $26 Million on Broadcom Stock. Should You Buy AVGO Too? - Barchart.com
WhitelistVideo Named Best Parental Control for Innovative AI-Driven “Guardrail Discovery” Technology - Barchart.com
Belcan Government Solutions Secures SHIELD Contract to Deliver Innovative Defense Capabilities for Missile Defense Agency - Barchart.com
Playground Play Equipment Innovation Sets New Benchmark for Safe, Engaging Spaces, Says Golden Times - Barchart.com
US ETF launches from 22nd to 29th January, 2026 - ETF Express
Pulmonary Arterial Hypertension Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Ribomic, Gmax Biopharm, Novartis, Cereno Scientific AB, Insmed - Barchart.com
Celiac Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | AMYRA Biotech AG, Equillium Bio., Chugai Pharmaceutical, Calypso Biotech - Barchart.com
Tradr Debuts Leveraged ETFs on Lumentum, Sandisk and Western Digital - The AI Journal
New ETFs let traders double daily moves in LITE, SNDK, WDC - stocktitan.net
Sealed Air Celebrates Innovation and Its Iconic Brand on National Bubble Wrap® Appreciation Day - Barchart.com
Weekly ETF Industry News Recap | January 19-23, 2026 - Trackinsight
Tradr Launches 2x Short Leveraged ETFs on APLD, IREN, LCID and NBIS - FinanceFeeds
Cathie Wood Is Doubling Down on Broadcom Stock. Should You? - Barchart.com
Cathie Wood Is Betting Big on This 1 Mining Stock. What’s the Bull Case? - Barchart.com
ProfitScaled Announces Innovative AI Driven Growth Model for Construction Businesses - Barchart.com
2 Top Flying Car Stocks That Cathie Wood Can’t Get Enough Of - Barchart.com
U.S. Equity ETF Tracker | Secures Multi-Hundred Million Dollar Data Leasing Deal with AMD; 2x Long RIOT ETF Surges 32%; Space Concept Stocks Rally Across the Board, 2x Long ASTS ETF Climbs Over 28% - 富途资讯
Tradr Launches Leveraged ETFs on Critical Metals, Ondas Holdings, UiPath and USA Rare Earth - TipRanks
Cathie Wood Is Buying Up Roblox Stock. What Is the Bull Case for RBLX in 2026? - Barchart.com
PETKIT Wins Microsoft AI Innovation Award: Why PUROBOT MAX PRO 2 Is Considered One of the Best Automatic Litter Boxes - Barchart.com
Ekinops 400G Transport Technology to Boost MuniNet's Network Capacity and Innovation - Barchart.com
Investment Managers Series Trust Ii Tradr 2X Short Innovation Daily Etf (NASDAQ:SARK)Research - intelligentinvestor.com.au
High-Yield Prospects: December 31 Edition - ETF Database
About Us | Laser Focus WorldTradr 2X Long SPY Monthly ETF (NYSE:SPYM) Stock Quote - FinancialContent
Cathie Wood Reduced Her Stake in Tesla: Is TSLA Stock a Buy, Hold, or Sell Now? - Barchart.com
Leveraged ETFs: 2x-3x Daily Returns Guide & Ticker List - Intellectia AI
Cathie Wood Keeps Buying the Dip in CoreWeave Stock. Should You? - Barchart.com
As Trump Takes a Stand Against Deere, How Should You Play the Blue-Chip Dividend Stock? - Barchart.com
High-Yield Prospects: December 10 Edition - ETF Database
New Tradr ETF Lets Traders Bet Against QQQ — Without The Daily Reset Drama - Benzinga
Tradr 2 X Long Innovation Etf (TARK) 財務データ
Tradr 2 X Long Innovation Etf (TARK) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.07%
大文字化:
|
ボリューム (24 時間):